How Eli Lilly’s weight-loss drug Mounjaro gained early lead against Novo Nordisk’s Wegovy in India

Eli Lilly’s blockbuster drug Mounjaro has quickly become the market leader in the segment, thanks to its strong clinical ...

BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares

BDF-GESTION sold 4,149 shares of Eli Lilly ( LLY 0.58%) stock during the quarter. The estimated transaction value was $3.09 million, using the average unadjusted closing price for the quarter. After ...

Eli Lilly Sues 2 Texas Companies for Allegedly Selling Replicas of Weight Loss Drugs

Two Texas compounding pharmacies are the latest to get sued in Eli Lilly’s multi-state battle to stop sales of replica ...

Judge Says Lilly Lacks Standing in Copycat Obesity Drug Suit (1)

Eli Lilly & Co. failed to prove in a federal court that a business selling copycat versions of its obesity drug causes harm ...
Fierce Pharma

Innovent, Lilly's mazdutide trumps Novo's semaglutide in head-to-head diabetes, weight loss study

An experimental GLP-1/glucagon (GCP) dual receptor agonist from Eli Lilly and its Chinese partner Innovent has bested Novo Nordisk’s reigning GLP-1 semaglutide in a phase 3 study across both b | ...
pharmaphorum

Pressure rises on Novo as Innovent drug tops Ozempic

Lilly's GIP/GLP-1 agonist Mounjaro (tirzepatide) also outperformed Ozempic, and the formulation of the drug for obesity, ...

30-stone dad who used to spend £25 a day on takeaways says ‘Mounjaro has given me my life back’ after losing 13 stone

Mark, who was slim during childhood, began to gain weight when he left school at 15 and took a job as a joiner for Leeds City Council. For the past 10 years, he has battled harder with his weight, ...